282 related articles for article (PubMed ID: 37173422)
1. Revisiting the role of mesenchymal stem cells in tuberculosis and other infectious diseases.
Devi A; Pahuja I; Singh SP; Verma A; Bhattacharya D; Bhaskar A; Dwivedi VP; Das G
Cell Mol Immunol; 2023 Jun; 20(6):600-612. PubMed ID: 37173422
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ABCG2 efflux pumps renders the Mycobacterium tuberculosis hiding in mesenchymal stem cells responsive to antibiotic treatment.
Kaur S; Angrish N; Gupta K; Tyagi AK; Khare G
Infect Genet Evol; 2021 Jan; 87():104662. PubMed ID: 33278633
[TBL] [Abstract][Full Text] [Related]
3. Emerging role of mesenchymal stem cells during tuberculosis: The fifth element in cell mediated immunity.
Khan A; Hunter RL; Jagannath C
Tuberculosis (Edinb); 2016 Dec; 101S():S45-S52. PubMed ID: 27743705
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterium tuberculosis evades host immunity by recruiting mesenchymal stem cells.
Raghuvanshi S; Sharma P; Singh S; Van Kaer L; Das G
Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21653-8. PubMed ID: 21135221
[TBL] [Abstract][Full Text] [Related]
5. In vitro And In vivo Immunomodulating Properties of Mesenchymal Stem Cells.
Chaudhary D; Trivedi RN; Kathuria A; Goswami TK; Khandia R; Munjal A
Recent Pat Inflamm Allergy Drug Discov; 2018; 12(1):59-68. PubMed ID: 29485014
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal Stem Cells and Tuberculosis: Clinical Challenges and Opportunities.
Zhang X; Xie Q; Ye Z; Li Y; Che Z; Huang M; Zeng J
Front Immunol; 2021; 12():695278. PubMed ID: 34367155
[TBL] [Abstract][Full Text] [Related]
7. Human mesenchymal stem cells: New sojourn of bacterial pathogens.
Kohli S; Singh Y; Sowpati DT; Ehtesham NZ; Dobrindt U; Hacker J; Hasnain SE
Int J Med Microbiol; 2015 May; 305(3):322-6. PubMed ID: 25648374
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulatory Mechanisms of Mesenchymal Stem Cells and Their Potential Clinical Applications.
Huang Y; Wu Q; Tam PKH
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077421
[TBL] [Abstract][Full Text] [Related]
9. MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu.
Lee BC; Shin N; Lee JY; Kang I; Kim JJ; Lee SE; Choi SW; Webster GA; Kang KS
Front Immunol; 2018; 9():1078. PubMed ID: 29892282
[TBL] [Abstract][Full Text] [Related]
10. Exosomes derived from mycobacterium tuberculosis-infected MSCs induce a pro-inflammatory response of macrophages.
Liu M; Wang Z; Ren S; Zhao H
Aging (Albany NY); 2021 Apr; 13(8):11595-11609. PubMed ID: 33872217
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
[TBL] [Abstract][Full Text] [Related]
12. The Immunomodulatory Properties of the Human Amnion-Derived Mesenchymal Stromal/Stem Cells Are Induced by INF-γ Produced by Activated Lymphomonocytes and Are Mediated by Cell-To-Cell Contact and Soluble Factors.
Bulati M; Miceli V; Gallo A; Amico G; Carcione C; Pampalone M; Conaldi PG
Front Immunol; 2020; 11():54. PubMed ID: 32117234
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells offer a drug-tolerant and immune-privileged niche to Mycobacterium tuberculosis.
Jain N; Kalam H; Singh L; Sharma V; Kedia S; Das P; Ahuja V; Kumar D
Nat Commun; 2020 Jun; 11(1):3062. PubMed ID: 32546788
[TBL] [Abstract][Full Text] [Related]
14. Human mesenchymal stem cell based intracellular dormancy model of Mycobacterium tuberculosis.
Singh VK; Mishra A; Bark S; Mani A; Subbian S; Hunter RL; Jagannath C; Khan A
Microbes Infect; 2020 Oct; 22(9):423-431. PubMed ID: 32562667
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Stromal Cells: an Antimicrobial and Host-Directed Therapy for Complex Infectious Diseases.
Shaw TD; Krasnodembskaya AD; Schroeder GN; Zumla A; Maeurer M; O'Kane CM
Clin Microbiol Rev; 2021 Dec; 34(4):e0006421. PubMed ID: 34612662
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal Stem Cell Immunomodulation: Mechanisms and Therapeutic Potential.
Song N; Scholtemeijer M; Shah K
Trends Pharmacol Sci; 2020 Sep; 41(9):653-664. PubMed ID: 32709406
[TBL] [Abstract][Full Text] [Related]
17. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
18. Mycobacterium tuberculosis programs mesenchymal stem cells to establish dormancy and persistence.
Fatima S; Kamble SS; Dwivedi VP; Bhattacharya D; Kumar S; Ranganathan A; Van Kaer L; Mohanty S; Das G
J Clin Invest; 2020 Feb; 130(2):655-661. PubMed ID: 31647784
[TBL] [Abstract][Full Text] [Related]
19. Exploring the role of soluble factors associated with immune regulatory properties of mesenchymal stem cells.
Bassi ÊJ; de Almeida DC; Moraes-Vieira PM; Câmara NO
Stem Cell Rev Rep; 2012 Jun; 8(2):329-42. PubMed ID: 21881832
[TBL] [Abstract][Full Text] [Related]
20. Mouse Bone Marrow Sca-1
Naik SK; Padhi A; Ganguli G; Sengupta S; Pati S; Das D; Sonawane A
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28739828
[No Abstract] [Full Text] [Related]
[Next] [New Search]
